Studies on the human leukocyte antigens in patients with polycystic ovary syndrome in a Japanese population - Possible susceptibility of HLA-A11 and -DRB1*0403 to patient population with polycystic ovary syndrome

American Journal of Reproductive Immunology

Volumn 55, Issue 4, 2006, Pages 301-306

  Kaibe, Mamiko ^a   Takakuwa, Koichi ^a   Murakawa, Haruo ^b   Ishii, Keisuke ^a   Tamura, Masaki ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Suzuki Hospital   (Japan)

Author keywords

Genotype; HLA class II; Human leukocyte antigen (HLA) class I; Polycystic ovary syndrome; Polymerase chain reaction restriction fragment length polymorphism

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEROLOGY; STATISTICAL SIGNIFICANCE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; JAPAN; POLYCYSTIC OVARY SYNDROME;

EID: 33644803615     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00369.x     Document Type: Article

References (21)

1. Adams J, Polson DW, Franks S: Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986; 293: 355-359.
2. Hull MG: Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987; 1: 235-245.
3. Givens JR: Familial polycystic ovarian disease. Endocrinol Metab Clin North Am 1988; 17: 771-783.
4. Wilroy RS, Jr, Given JR, Wiser WL, Coleman SA, Andersen RN, Summitt RL: Hyperthecosis: An inheritable form of polycystic ovarian disease. Birth Defects 1975; 11: 81-85.
5. Ferriman D, Purdie A: The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol 1979; 11: 291-300.
6. Govind A, Obhrai MS, Clayton RN: Polycystic ovaries are inherited as an autosomal dominant trait: Analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 1999; 84: 38-43.
7. Nepom G, Erlich H: MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991; 9: 493-525.
8. Thomson G: HLA diseaMe associations: models for the study of complex human genetic disorders. Crit Rev Clin Lab Sci 1995; 32: 183-219.
9. Lobo RA, Goebelsmann U: Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. Am J Obstet Gynecol 1980; 138: 720-726.
10. Hague WM, Adams J, Algar V, Drummond V, Schwarz G, Bottazzo GF, Jacobs HS: HLA associations in patients with polycystic ovaries and in patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. Clin Endocrinol 1990; 32: 407-415.
11. Ober C, Weil S, Steck T, Billstrand C, Levrant S, Barnes R: Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DQA1*0501. Am J Obstet Gynecol 1992; 167: 1803-1806.
12. Terasak PI, McClelland JD: Microdroplet assay of Ruman serum cytotoxins. Nature 1964; 204: 998-1000.
13. Ota M, Seki T, Fukushima H, Tsuji K, Inoko H: HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992; 39: 187-202.
14. Svejgaard A, Jersild C, Nielsen S, Bodmer WF: HLA antigens and disease: statistical and genetical consideration. Tissue Antigens 1974; 4: 95-105.
15. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T: Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. HLA 1991 Proceedings of the 11th International Histocompatibility Workshop and Conference, Vol. 1, K Tsuji, M Aizawa, T Sasazuki (eds). Oxford, Oxford University Press, 1992, pp 1065-1220.
16. Hashimoto M, Kinoshita T, Yamasaki M, Tanaka H, Imanishi T, Ihara H, Ichikawa Y, Fukunishi T: Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens 1994; 44: 166-173.
17. Opelz G, Mytilineos J, Scherer S, Dunckley H., Trejaut J, Chapman J, Middleton D, Savage D, Fischer O, Bignon J, Bensa J, Albert E, Noreen H: Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet 1991; 338: 461-463.
18. Margulies DH: The major histocompatibility complex. Fundamental Immunology, 4th edn, WE Paul (ed.). Philadelphia, PA, Lippincott-Raven Publishers, 1999, pp 263 263-285.
19. Wedell A: Molecular approaches for the diagnosis of 21-hydroxlase deficiency and congenital adrenal hyperplasia. Clin Lab Med 1996; 16: 125-137.
20. Yarman S, Dursun A, Oguz F, Alagol F: The prevalence, molecular analysis and HLA typing of late-onset 21-hydroxylase deficiency in Turkish woman with hirsutism and polycystic ovary. Endocr J 2004; 51: 31-36.
21. Zawadski JK, Dunaif A: Diagnostic criteria for polycystic ovary syndrome towards a rational approach. In Polycystic Ovary Syndrome, F Dunaif, JR Givens, FP Haseltine, GR Merriam (eds). Oxford, Blackwell Scientific Publication, 1992, pp 377-384.